Acclinate Genetics aims to create a more efficient market for connecting healthcare providers in need of genomic screening and diagnostic services with the specialized laboratories performing such services. Acclinate leverages a comprehensive network of specialized partner labs to provide healthcare providers with a centralized source for fast, accurate, and reliable genetic screening and diagnostic services.
Relevant Diagnostics Empowering Actionable Therapy®
Alimetrix is a molecular diagnostic company whose mission is to provide clinicians with actionable diagnostic information. With unique disease insight, coupled with proprietary technologies, Alimetrix is able to provide exceptionally accurate test results in a timely manner. Being armed with finely detailed and accurate information allows clinicians to gain a clear understanding of the therapeutic needs of the patient. As part of our clinician partnership we seek to provide best-in-class information, helping to facilitate better patient outcomes and actively reduce patient suffering.
ARIEL is an advanced diagnostics laboratory and bioinformatics services company providing genomics-based tests that aid in the diagnosis, monitoring and treatment of Complex Chronic Disease and Disorders. Our mechanistic diagnostic process approach is intended to enable informed intervention prior to the development of end-stage outcomes. We believe that ARIEL’s technologies can lead a paradigm shift from single gene (Mendelian) genetics to multifaceted, complicated gene to gene interactions that interface with familial and environmental factors to provide a more comprehensive view of disease trajectory and precise therapeutic options.
BioDynami Corporation is a biotechnology company that provides innovative solutions for life science research and development. Currently, BioDynami is focusing on next generation sequencing (NGS) and molecular cloning. We provide reagents for NGS, DNA cloning, and PCR cloning. We also offer services for NGS library construction, custom vector design, and DNA cloning. Our goal is to provide the best solutions in the field to make Research and Development life easier.
CFDRC’s mission is to develop and commercialize innovative technologies. Most of the company’s work is performed through highly competitive research contracts from government agencies. Three core focus areas are aerospace and defense, biomedical and life sciences, and energy and materials.
Celsion is a fully-integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA – or DNA-based therapies. The Company’s lead program is ThermoDox®, a propretary heat-activated liposomal encapsulation of doxorubicin, currently in Phase III development for the treatment of primary liver cancer. The pipeline also includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers. Celsion has three platform technologies for development of novel nucleic, acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlus™, TheraSilence™ and RAST.
Conversant Bio provides biospecimens and ancillary services to researchers focused on oncology, hematology and immunology research. In 2013, Conversant Bio expanded services to include neurology, endocrinology and pulmonology. Conversant Bio provides primary tissues and cells matched with the clinical information scientists need to better validate their research so new drugs can reach the patient bedside more quickly. Most projects are prospective in nature; Conversant Bio collects and processes specimens that meet each researcher’s specific criteria for patient selection and sample preparation. Conversant Bio also continues to expand its ability to source normal biospecimens to support general immunology research. Conversant Bio is currently involved in more than 160 active preclinical or clinical studies with scientists in the U.S., Europe and Asia.
Diatherix is an innovative, CLIA certifed, molecular diagnostic laboratory utilizing proprietary TEM-PCR™ (Target Enriched Multiplex Polymerase Chain Reaction) technology for precise detection of infectious diseases, linking diagnostics to therapeutics. TEM-PCR technology is a unique, multiplex amplification platform designed to overcome the challenges that exist with conventional laboratory methods and real-time PCR applications. Diatherix Distinctions:
- Simultaneous identification of bacteria, viruses, parasites, Candida and antibiotic resistance
- Detection of bacteria in the presence of antibiotics
- Increased sensitivity and specificity
- Simplicity of single sample collection
- One-day results (determined by sample receipt)
Envision Genomics is a comprehensive genomic medicine enabler for Children’s Hospitals committed to improving the quality & reducing the cost of healthcare by unlocking the genomic sequence for more effective patient care. Envision offers clinical implementation, clinical grade sequencing, informatics, and precision medicine care delivery training enabling physicians to practice true precision medicine.
Foresight Biosciences provides technology for glycobiology research with an emphasis on creating tools and in vitro technologies to advance protein-based drug development. Most FDA-approved protein glycoconjugates have very specific structures that affect their function and distribution. Therapeutic proteins derived from non-human cells often exhibit improper glycosylation that require modification prior to administration. Foresight Biosciences has developed technology to facilitate protein posttranslational modification, glycoconjugation and glycan analysis. The company offers benchtop assays for glycoprotein terminal fingerprint analysis, enzymes and convenient kits for identifying, repairing, and modifying protein glycosylation.
GeneCapture, a startup company in the research and development phase, is prototyping a portable, automated device to detect and identify pathogens in less than one hour. This rapid detection device could be applied to human and animal health as well as agriculture. The company’s technology is based on a patented DNA hybridization process and on a patented high-performance optical scanning technique. GeneCapture is participating in a validation pilot with Huntsville Hospital. Lab proofs have been conducted on human, plant and animal pathogens.
iCubate® is a molecular diagnostic company with groundbreaking technology and an innovative platform to detect infectious diseases. The company is currently developing tests for companies and organizations both in the U.S. and overseas. Founder Jian Han, M.D., Ph.D., developed patent-protected arm-PCR reaction that addresses up to 30 genes in one test used by iCubate®. The research and potential clinical possibilities are endless in designing tests to differentiate between organisms and drug resistance markers. The iCubate® System (iC-System™) performs extraction, amplification and detection using the patented iC-Cassette™. The iC-System™ is being marketed and sold in the research-use market. Customers include U.S. government agencies and universities along with government agencies and organizations in Asia. The iC-System™ can be customized to detect a variety of organisms.
iRepertoire uses immune repertoire sequencing technology to access the body’s immunological memory, or “logbook” of all past infection and disease. Sequencing the immune repertoire will potentially yield insights into the nature of the body’s immune response to disease and infection. The future market for iRepertoire and other companies in the field will be in clinical applications. Right now, customers of all the companies offering immune sequencing services will be early adopters in this field, doing immunology analysis, vaccine studies and looking for biomarkers for diseases. iRepertoire is part of the nonprofit initiative R10K, with HudsonAlpha, which is aiming to study the immune repertoire of 100 different diseases.
iXpressGenes is a bioengineering and synthetic biology company focused on protein crystallization, specialty enzymes and contract research associated with genetic markers. iXG is conducting ongoing research to address better techniques for crystal growth. iXG has pioneered the trace labeling protocol which is considered a best practice in labs in Europe and the U.S. iXG provides single solutions, specialty enzymes and bio-lab supplies. The company has exclusive access to microbes from the Atlantic Mid Ridge Rainbow Deep Sea Vents. These microbes have led to engineered enzymes with special traits, speeding reactions in PCR and providing more temperature stable polymerases. Scientists at iXG are exploring synthetic biology solutions in the areas of healthcare, environment and defense.
The Jackson Conference Center is located on the CRP Biotech Campus, adjacent to the HudsonAlpha Institute for Biotechnology. The 22,000-square-foot center houses two 4,000-square-foot halls that can be combined into one large, 8,000-square-foot space. Smaller meeting rooms also accommodate a variety of configurations. A stage and a cafe are part of the center’s amenities. The JCC also has a two-story entrance hall with several informal seating areas.
Kailos Genetics, through its CLIA Services Laboratory, analyzes DNA for “genetic clues” associated with drug response, adverse response and diagnosis of disease. These clues enable physicians to proactively identify responders and non-responders to certain drug therapies, avoid serious adverse drug reactions that are genetically linked and diagnose inherited and non-inherited diseases. The CLIA Services Laboratory at Kailos Genetics provides drug metabolism/pharmacogenomic testing services for drugs and conditions commonly associated with or used to treat cardiac disease, mental health issues and pain syndromes. Kailos Genetics services all physician specialties and has business-to-business relationships to leverage its TargetRich technology in non-physician and research markets.
Kymanox is a premier technical products and project management company. We are experts in providing our clients in the Biotechnology, Pharmaceutical, and Medical Device industries with engineering, scientific, regulatory, and process operations support. We help bring products from bench to patient. We differentiate ourselves by offering a broad range of technical services and products with turnkey project delivery. We serve clients globally from our headquarters in Durham (RTP), North Carolina and branch hubs across the USA.
Leavendary provides craft brewers customized big-brewery biology that fits the craft brewing context. Innovative craft brewers continually produce newrecipes that create new and responsive biology requirements for Leavendary. Leavendary ensures brewers have “pitch perfect” yeast, a first-class quality program, and the biology expertise they need to succeed in a highly competitive market.
Microarrays Inc. is a technology company that uses precision robotics to manufacture a product called a microarray. Microarrays are orderly arrangements of capture probes usually made of DNA and/or proteins. These probes are able to “capture” biological information, allowing researchers to rapidly sort through complex samples and identify the presence or absence of targets of interest. Within healthcare, everyone from the patient to the providing institution benefits from the use of array-based tools. For the patient, the diagnostic time savings can mean the difference between a positive or negative outcome, especially in regard to infectious diseases. The technologies developed at MI span the full spectrum of array production, from early project conception to manufacturing, final quality control and product validation. MI develops all of the motion-control software, printing robotics and microfluidic deposition technologies used by MI to provide high-throughput capability to any project. While best known in the industry for microarray production and assay development, MI has expanded to include gene expression laboratory services.
MVW Nutritionals is a privately held company, with the mission of providing leading edge nutritional supplements and vitamins for persons who have cystic fibrosis and other gastro intestinal disorders. Our goal is to deliver exceptional product profiles, coupled with outstanding service. We believe that quality in what we do, at a reasonable price, are important, and we are committed to this mission.
Founded by physicist Ron Barnes in 1977, Prozone Water Products Inc. provides unique solutions and leading edge Ozone, Germicidal UV-C, and Advanced Oxidation Process technologies for the purification of fluids, air, and surfaces. Using their Hybrid Cold Plasma and AOP systems, Prozone focuses on the elimination of Legionella, Cryptosporidium (“Crypto”), E-coli, Pseudomonas, Staphylococcus, MRSA, C-Diff and other pathogens found in hospitals, cruise ships, recreational facilities, and rehabilitation facilities. Additionally, Prozone’s systems increase plant health and inhibit inherent issues of mold, fungus, bacteria, and coliform through the oxidation and DNA modification process.
Serina Therapeutics, Inc. is a privately-held pharmaceutical company that is advancing novel therapeutics for Parkinson’s disease, restless leg syndrome, cancer, inflammation and pain using its proprietary, patented polymer technology. The company has created new pharmaceutical candidates using polyoxazoline (POZ) – a safe, water-soluble polymer to which we can attach a variety of small molecules, proteins, peptides and DNA.
Location: HudsonAlpha Suite 1222
At transOMIC technologies we believe deeply in the power of science and technology to advance our understanding of biological systems and ultimately improve the quality of life. Our company provides innovative tools and strategies for life science research to help unravel genetic complexity and understand disease development. This mission, coupled with a good understanding of the tools that life science researchers need, drives our focus to be a research partner; delivering technologies in a cost-effective and technically supported manner to enable discovery across the genome. We have the largest offering of gene content to enable scientists across the world, academic and commercial, to perform gene knockdown and over-expression studies. These types of studies produce insights into gene function ultimately providing biological understanding of disease and possibilities for therapies. Most of our leading-edge products are developed through ongoing collaborations with academic thought leaders.
Sulfilatec, Inc. is a preclinical-stage biotechnology company aiming to transform clinical outcomes in dialysis. The company is developing novel treatments tailored to the unique biochemical profile of dialysis patients in order to reduce the elevated morbidity and mortality rates associated with dialysis treatments.
Trideum Biosciences is a wholly owned subsidiary of Trideum Corporation, headquartered in Huntsville, AL, and employs a uniquely tailored approach for providing scientific solutions to clients, such as cost-effective, high-quality, custom DNA for diagnostic assay development and validation. Led by Dr. Mina Izadjoo, Ph.D., the scientists at Trideum Biosciences have expertise in conducting various testing and evaluation studies as well as decades of experience in research and lab operations. These studies include anti bio-film efficacy testing; conducting antibody and cell-based assays and extracting high quality genomic material from infectious agents. Additionally, Trideum Biosciences offers scientific consultation and partnerships in scientific grant writing. Trideum Biosciences has partnerships across the country with our primary laboratories located in Frederick, Maryland, and an office at HudsonAlpha focused on developing innovative devices starting with applications of cold plasma technology.
Ubiquity Genomics provides tools for targeted DNA sequencing. The company’s proprietary technology allows researchers to focus genetic and epigenetic analyses on specific regions of the genome at a fraction of the cost of other commercially available approaches. Release of MHC Complete, the company’s first product, is anticipated in 2014. MHC Complete reagents will enable scientists to sequence the entire MHC locus, a region of great importance to disease research.
Volatile Analysis Corporation (VAC) is a privately held company that specializes in volatile chemical detection and measurement for medical and industrial purposes. The research group focuses on links between biomarkers and diagnosis of human and animal diseases, an area collectively known as volatile metabolomics. Scientists develop technologies to enhance successful volatile metabolite capture from various biological sources. Extraction technologies also have industrial applications. The analytical services group specializes in quantification of trace level and ultra-trace level (ng/g or parts per trillion and lower) chemicals responsible for odor and aroma. Sensory trained staff also review industrial processes and coordinate odor remediation efforts. Examples of industry served include: paper, packaging, pharmaceutical, food, beverage, textiles, manufacturing, automotive, apparel, and cosmetic.